These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1630554)

  • 1. Vinorelbine therapy in a hemodialyzed patient.
    Rollino C; Milongo R; Schaerer R; Cordonnier D
    Nephron; 1992; 61(2):232-3. PubMed ID: 1630554
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
    Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
    Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
    Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
    Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
    George MJ; Heron JF; Kerbrat P; Chauvergne J; Goupil A; Lebrun D; Guastalla JP; Namer M; Bugat R; Ayme Y
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):30-2. PubMed ID: 2652318
    [No Abstract]   [Full Text] [Related]  

  • 7. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A summary of vinorelbine (Navelbine) safety data from North American clinical trials.
    Hohneker JA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Localized epidermal necrolysis after intravenous injection of vinorelbine].
    Misery L; Perrot JL; Vergnon JM; Boucheron S; Emonot A; Claudy A
    Presse Med; 1992 Dec 19-26; 21(44):2153. PubMed ID: 1297136
    [No Abstract]   [Full Text] [Related]  

  • 10. Vinorelbine: a horse of a different color?
    Pinedo HM; Van Groeningen CJ
    J Clin Oncol; 1994 Sep; 12(9):1745-7. PubMed ID: 8083696
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and tolerance of Navelbine in phase I-II clinical studies.
    Besenval M; Delgado M; Demarez JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.
    Thallinger C; Lang I; Kuhar CG; Bartsch R; Singer CF; Petruzelka L; Melichar B; Knittelfelder R; Brodowicz T; Zielinski C
    BMC Cancer; 2016 Feb; 16():121. PubMed ID: 26887956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.
    Pace A; Bove L; Nisticò C; Ranuzzi M; Innocenti P; Pietrangeli A; Terzoli E; Jandolo B
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):409-11. PubMed ID: 8890782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine monochemotherapy in non-small-cell lung cancer: experience in patients with low performance status.
    Masotti A; Zannini G; Poggi R; Morandini GC
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):197-200. PubMed ID: 8087113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion vindesine in solid tumors.
    Bodey GP; Yap HY; Yap BS; Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():39-45. PubMed ID: 7438120
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
    Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
    J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
    Winer EP; Chu L; Spicer DV
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?
    Dittrich C; Zifko U; Fazeny B; Fiegl M; Grisold W; Huber H
    Ann Oncol; 1994 May; 5(5):473-4. PubMed ID: 7915538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].
    Yokota Y; Suzuki T; Narahashi T; Takizawa J; Kojima M; Shimada R
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1525-9. PubMed ID: 18799905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.